Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Health Care Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy

Fiscal year ending 2024. Filed on July 31, 2025.

1 Letterman Drive D3500
San Francisco, California 94129

Parker Institute for Cancer Immunotherapy (EIN: 47-3355381) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Parker Institute for Cancer Immunotherapy, a 501(c)(3) charitable organization, reported compensation for 9 out of 26 total employees. Among the employees shown here, the average compensation is $691,703. The highest compensated employee at Parker Institute for Cancer Immunotherapy is John Connolly, Ph.D. with fiscal year 2024 compensation of $927,546.

Revenue, expenses, and employee compensation

Revenue

$66,947,169

Expenses

$54,471,034

Employee compensation

$10,443,144
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

John Connolly, Ph.D.
Chief Scientific Officer
$927,546
$855,710 No related comp$71,836
Kevin Marks
Chief Legal Officer
$912,919
$840,863 No related comp$72,056
Ute Dugan, M.D.
Chief MED Officer THRU 6/24
$820,319
$715,023 No related comp$105,296
Tarak Mody
Chief Business Officer
$704,146
$632,310 No related comp$71,836
Shane Corcoran
Senior Vice President, Strat. OPS and Comms
$700,400
$669,429 No related comp$30,971
Sara Coblin
Senior Vice President Finance and Admin.
$614,697
$564,812 No related comp$49,885
Marko Spasic
SR Medical Director, HEAD of MED
$427,249
$418,090 No related comp$9,159
Christen Dipetrillo
HEAD of Intellectual Property
$426,351
$354,287 No related comp$72,064
Susan Dawson
Secretary
$0

Benchmark Employee Compensation

Non-Employee Board Members

Ben Horowitz
Director
Bob Hugin
Director
Bob Nelsen
Director
Bob Pittman
Director
Bruce Parker, Ph.D.
Director
Eric Esrailian, M.D., Mph
Director
Jeff Huber
Director
Jeffrey A Bluestone, Ph.D.
Vice Chair and Director
Margo Georgiadis
Director
Michael Polansky
Executive Vice President and Director
Ramy Ibrahim, M.D.
Director
Reed Jobs
Director

Contractors

Stanford University
Patent and License Exp
$1,345,434
Regents of University of Cal San Franc
Patent/Clinic Exp
$1,017,795
The Trustees of the University of PA
Patent/Clinic Exp
$653,093
Regents of University of Cal Los Angel
Patent and License Exp
$548,409
University of Texas MD Anderson Cancer C
Clinical Trial Exp
$454,564

Mission Statement

THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY'S (PICI) MISSION IS TO ACCELERATE THE DEVELOPMENT OF BREAKTHROUGH IMMUNE THERAPIES TO TURN ALL CANCERS INTO CURABLE DISEASES.

Revisions to this organization profile

July 31, 2025:
2024 Parker Institute for Cancer Immunotherapy 990 filed
August 1, 2024:
2023 Parker Institute for Cancer Immunotherapy 990 filed
November 14, 2023:
2022 Parker Institute for Cancer Immunotherapy 990 filed

Get an email when new compensation information is released for Parker Institute for Cancer Immunotherapy

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →